Non-invasive ultrasound neural modulation: Merge Labs and Forest Neurotech technical whitepaper on molecular neurostimulation approach
Summary
Merge Labs and Forest Neurotech published a technical description of their non-invasive BCI approach: using ultrasound as a physical carrier to deliver molecular agents (biological or synthetic) to specific neurons, enabling both reading neural activity (via molecular reporters) and writing to neural circuits (via molecular effectors) without electrodes or surgery. The approach builds on Mikhail Shapiro's Caltech laboratory work on acoustic reporter genes, ultrasound neuroimaging, and molecular tools for neural circuit interrogation, combined with Forest Neurotech's applied neural engineering work.
Why it matters
The molecular ultrasound approach to non-invasive BCI is the most technically ambitious neural interface concept currently funded at commercial scale. If acoustic reporter genes and ultrasound-delivered molecular effectors can achieve neuron-level specificity at depth in the human brain โ bypassing the fundamental physics limits of EEG and conventional FUS โ Merge Labs would produce a neural interface with the resolution of implanted electrodes and the safety of non-invasive sensing. The $252M seed reflects investor belief this is achievable.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trial